TrialInvestigational new drugs2020

Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial.

Jun Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.